Advertisement

Table of Contents

May 01, 1983; Volume 23,Issue 3

You have access
Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells.
R A Frye and R W Holz

Molecular Pharmacology May 1983, 23 (3) 547-550;
You have access
Modification of the binding properties of muscarinic receptors by gallamine.
J M Stockton, N J Birdsall, A S Burgen and E C Hulme

Molecular Pharmacology May 1983, 23 (3) 551-557;
You have access
The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures.
C W Lin and J M Musacchio

Molecular Pharmacology May 1983, 23 (3) 558-562;
You have access
3h-substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations.
C M Lee, J A Javitch and S H Snyder

Molecular Pharmacology May 1983, 23 (3) 563-569;
You have access
Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
P J Barnes, B E Skoogh, J A Nadel and J M Roberts

Molecular Pharmacology May 1983, 23 (3) 570-575;
You have access
Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
A Enjalbert and J Bockaert

Molecular Pharmacology May 1983, 23 (3) 576-584;
You have access
Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
D R Sibley and I Creese

Molecular Pharmacology May 1983, 23 (3) 585-593;
You have access
[3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
D A Kendall, D P Taylor and S J Enna

Molecular Pharmacology May 1983, 23 (3) 594-599;
You have access
A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
M E Reith, H Sershen, D L Allen and A Lajtha

Molecular Pharmacology May 1983, 23 (3) 600-606;
You have access
Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
A Dumbrille-Ross and S W Tang

Molecular Pharmacology May 1983, 23 (3) 607-613;
You have access
Ionization processes of some harmala alkaloids.
K T Douglas, R K Sharma, J F Walmsley and R C Hider

Molecular Pharmacology May 1983, 23 (3) 614-618;
You have access
High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization.
G L Craviso and J M Musacchio

Molecular Pharmacology May 1983, 23 (3) 619-628;
You have access
High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments.
G L Craviso and J M Musacchio

Molecular Pharmacology May 1983, 23 (3) 629-640;
You have access
Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat.
W L Combest and D H Russell

Molecular Pharmacology May 1983, 23 (3) 641-647;
You have access
Glucocorticoids increase GTP-dependent adenylate cyclase activity in cultured fibroblasts.
G S Johnson and C J Jaworski

Molecular Pharmacology May 1983, 23 (3) 648-652;
You have access
Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz

Molecular Pharmacology May 1983, 23 (3) 653-664;
You have access
Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
P J Silver and J T Stull

Molecular Pharmacology May 1983, 23 (3) 665-670;
You have access
Ionic and metabolic requirements for stimulation of secretion by ouabain in bovine adrenal medullary cells.
G Pocock

Molecular Pharmacology May 1983, 23 (3) 671-680;
You have access
Ion movements in isolated bovine adrenal medullary cells treated with ouabain.
G Pocock

Molecular Pharmacology May 1983, 23 (3) 681-697;
You have access
Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
G Jung, G Hennings, M Pfeifer and W G Bessler

Molecular Pharmacology May 1983, 23 (3) 698-702;
You have access
Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
M C Edwards, A M Nouri, D Gordon and F J Evans

Molecular Pharmacology May 1983, 23 (3) 703-708;
You have access
Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
P H Fischer, M A Weddle and R D Mossie

Molecular Pharmacology May 1983, 23 (3) 709-716;
You have access
Inhibition of brain carboxylesterases by neurotoxic and nonneurotoxic organophosphorus compounds.
J M Chemnitius and R Zech

Molecular Pharmacology May 1983, 23 (3) 717-723;
You have access
Effects of nitrous oxide and methotrexate administration on hepatic methionine synthetase and dihydrofolate reductase activities, hepatic folates, and formate oxidation in rats.
K A Black and T R Tephly

Molecular Pharmacology May 1983, 23 (3) 724-730;
You have access
Identification of 2-imidazolines as anti-sickling agents.
H Chang, S M Ewert and R L Nagel

Molecular Pharmacology May 1983, 23 (3) 731-734;
You have access
Modulation of microsomal benzo[a]pyrene metabolism by DNA.
G M Keller and C R Jefcoate

Molecular Pharmacology May 1983, 23 (3) 735-742;
You have access
22-Ketocholesterol. A potent competitive inhibitor of cytochrome P-450scc-dependent side-chain cleavage of cholesterol.
J D Lambeth

Molecular Pharmacology May 1983, 23 (3) 743-747;
You have access
Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
E H Jeffery and G J Mannering

Molecular Pharmacology May 1983, 23 (3) 748-757;
You have access
Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg

Molecular Pharmacology May 1983, 23 (3) 758-760;
You have access
Cysteine conjugate beta-lyase.
J Stevens and W B Jakoby

Molecular Pharmacology May 1983, 23 (3) 761-765;
You have access
An electron spin resonance study of the activation of benzidine by peroxidases.
P D Josephy, T E Eling and R P Mason

Molecular Pharmacology May 1983, 23 (3) 766-770;
You have access
Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
G Benga, M Ionescu, O Popescu and V I Pop

Molecular Pharmacology May 1983, 23 (3) 771-778;
You have access
Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
J L Vannice, J R Grove and G M Ringold

Molecular Pharmacology May 1983, 23 (3) 779-785;